Indication

Pulmonary blastomycosis

Pulmonary blastomycosis is an invasive fungal respiratory infection caused by inhaling the conidia of thermally dimorphic fungi of the genus *Blastomyces*, primarily *Blastomyces dermatitidis* or *Blastomyces gilchristii*. Read more about Pulmonary blastomycosis

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Pulmonary blastomycosis therapies.

Showing 1–1 of 1 drugs

Filter & compare in the drug finder →Opens the drug finder with Pulmonary blastomycosis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Pulmonary blastomycosis.

Pulmonary blastomycosis is an invasive fungal respiratory infection caused by inhaling the conidia of thermally dimorphic fungi of the genus *Blastomyces*, primarily *Blastomyces dermatitidis* or *Blastomyces gilchristii*.

After deposition in the lower respiratory tract, the organism transitions into a pathogenic yeast phase that elicits a characteristic pyogranulomatous inflammatory response in both immunocompetent and immunocompromised hosts.

Clinical manifestations range from subclinical disease or acute, self-limited pneumonia presenting with fever, cough, and chest pain to chronic, progressive pulmonary illness marked by consolidation, cavitation, or mass-like infiltrates that can mimic tuberculosis or malignancy.

Severe disease can rapidly lead to respiratory failure or acute respiratory distress syndrome, with the potential for hematogenous dissemination to extrapulmonary sites such as the skin, bone, and central nervous system.

Personalize your experience

Follow Pulmonary blastomycosis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it